How did you hear about the AAMP Conference series?
Referral By Speaker: who?
2 out of 9
Evaluating The Speakers
How good was each speaker, in terms of preparation, presentation skills, quality of slides, question handling and so on.
Please number each box and rate the speakers from 1-10..... 10 being your best speakers.
You are not assessing the speakers against each other.
Rate the Speakers - Paul Anderson, N.M.D.
Rate the Speakers - Jill Crista, N.D.
Rate the Speakers - Lauren Tessier, N.D.
Rate the Speakers - Mary Beth Ackerley, M.D., MD(H), ABIHM
Rate the Speakers - Kellyn Milani, N.D.
Specific speaker comments (Your additional input is appreciated)
4 out of 9
Evaluating The Content - Day 1
Topics should be informative and clear in their interpretation.
Please rate the content from 1-10....10 being the topics you benefited from most.
You are not assessing the topics against each other.
Immunology Updates “A to Z” ANDERSON
Immune Disruptors beyond Mycotoxins ANDERSON
Immune Suppressive Mechanism of Mold CRISTA
Mold & Mycotoxin Induced Endocrine Disruption TESSIER
Clinical and Laboratory Assessment of Non- mycotoxin Immune Disruptors ANDERSON
Immunomodulators Part-1: Therapies of Note ANDERSON
Immune Disruption: Strategies for Clinicians EXPERT PANEL DISCUSSION 1
Specific topic comments (Your additional input is appreciated)
5 out of 9
Evaluating The Content - Day 2
Topics should be informative and clear in their interpretation.
Please rate the content from 1-10....10 being the topics you benefited from most.
You are not assessing the topics against each other.
Mycotoxin Assessment: The Good (and Not so Good...) CRISTA
Legal and Ethical Implications of Mold Related Diagnoses TESSIER
Mold Treatment Approach Part-1 & 2 CRISTA
Identity and Addressing Clinical Reactions in Mold Illness TESSIER
Mold & Mycotoxin Induced Fatigue TESSIER
Mold & Mycotoxin Illness in The Pediatric Population TESSIER
Mold/Mycotoxin Clinical Management EXPERT PANEL DISCUSSION 2
Specific topic comments (Your additional input is appreciated)
6 out of 9
Evaluating the Content - Day 3
Topics should be informative and clear in their interpretation.
Please rate the content from 1-10....10 being the topics you benefited from most.
You are not assessing the topics against each other.
Neuropsychiatric effects of Mast Cell Activation, Related Conditions and NeuroQuant Imaging ACKERLEY
Chronic Inflammatory Response Syndrome (CIRS) Part-1 & 2 MILANI
Immunomodulators Part-2: Prescription and Management ANDERSON
Detoxification Therapies (Sauna, HBOT, NEUROFEEDBACK, Light, Liver/Kidney, Real Glutathione and Detox Nutrition, etc.) ANDERSON
Pharmacology: Anti-Fungal, Parasitic, Biofilm and other Rx Therapies ANDERSON
Immune Dysregulation Clinical Concepts EXPERT PANEL DISCUSSION 3
Specific topic comments (Your additional input is appreciated)
7 out of 9
CONFERENCE LOGISTICS, specifically,
Our Advanced Applications in Medical Practice Conferences are based on continuous improvement.
With the changes in delivery due to COVID-19, your comments on this occasion will be particularly helpful.
Please rate how we did from 1-10........... 10 being the highest rating.
Event Organization (Did AAMP keep you updated with easy to follow information, before and during the conference?)
Problem Solving ( In this 2020 Virtual World, how well did AAMP address any issues you had during the conference?)
Virtual Lobby (How easy was it to navigate, from the “Stage” to the “Expo” to the “People”?)
Virtual Expo (For the most part, was the material presented useful and was your interaction with exhibitors helpful?)
Your Fellow Attendees (You had with the opportunity to chat with other attendees. How useful did you find it?)
Did you gain from the level of learning anticipated
Overall, was it a good mix of speakers
IF THIS WASN’T YOUR 1st VIRTUAL CONFERENCE, HOW DID IT RATE AGAINST OTHERS YOU’VE ATTENDED?
General comments (Your additional input is appreciated)
8 out of 9
Would you consider attending future AAMP live “virtual” conferences?
AAMP’s future desire is to offer “in-person” conferences again when it is safe and appropriate to do so. Until that time, would you consider attending future AAMP live “virtual” conferences?
9 out of 9
